Corbus (CRBP) up 19%. Only "news" is a video posted by Rick from a Utah news station which mentions Resunab, Corbus' lead compound. The bigger driver is likely recovering from panic regarding the Bial trial disaster which involved a FAAH inhibitor. But FAAH is part of the cannabinoid pathway targeted by Resunab, and investors shot first and asked questions later. I think that's what took it down so hard, and while it is bouncing, I haven't seen anyone other than myself defend it. Maybe Jason Napodano of Zack's - who follows it - will get around to it. If so, that might goose the shares further.
Obviously, this is one I follow and I own a small position. Speculative program that has shown well so far, possible financing risk this year. Way oversold. Still. But that doesn't mean it can't tank again in a market meltdown, or that there won't be profit taking, as it is up over 30% from yesterday's lows.
Now at $1.43, I added a half position at $1.03 yesterday and am dithering about selling yesterday's trading slug ( currently my total position is still underwater ).
Most discussion is on Rick's momo/tif thread.
Cheers, Tuck |
